Page last updated: 2024-09-04

canertinib and ldc4297

canertinib has been researched along with ldc4297 in 1 studies

Compound Research Comparison

Studies
(canertinib)
Trials
(canertinib)
Recent Studies (post-2010)
(canertinib)
Studies
(ldc4297)
Trials
(ldc4297)
Recent Studies (post-2010) (ldc4297)
124965808

Protein Interaction Comparison

ProteinTaxonomycanertinib (IC50)ldc4297 (IC50)
Cyclin-dependent kinase 1Homo sapiens (human)0.053
Cyclin-dependent kinase 2Homo sapiens (human)0.0064
Cyclin-dependent kinase 7Homo sapiens (human)0.0034
Cyclin-dependent kinase 9Homo sapiens (human)1.711

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bharate, SB; Raghuvanshi, R1

Other Studies

1 other study(ies) available for canertinib and ldc4297

ArticleYear
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022
chemdatabank.com